Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
- 6 July 2004
- journal article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 9 (10), 897-899
- https://doi.org/10.1038/sj.mp.4001548
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with SchizophreniaNeuropsychopharmacology, 2004
- Serum S100B is increased during early treatment with antipsychotics and in deficit schizophreniaSchizophrenia Research, 2003
- S100B in brain damage and neurodegenerationMicroscopy Research and Technique, 2003
- Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussioncclm, 2003
- S100 proteins structure functions and pathologyFrontiers in Bioscience-Landmark, 2002
- Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatologyMolecular Psychiatry, 2001
- Increased serum S100B protein in schizophrenia: a study in medication-free patientsJournal of Psychiatric Research, 2001
- Schizophrenia as a Disorder of Developmentally Reduced Synaptic ConnectivityArchives of General Psychiatry, 2000
- Tripartite synapses: glia, the unacknowledged partnerTrends in Neurosciences, 1999
- The reduced neuropil hypothesis: a circuit based model of schizophreniaBiological Psychiatry, 1999